Teva’s proposed settlement could cost drugmaker pennies on the dollar

Israel-based Teva is looking to reach a nationwide settlement over its role in selling opioid painkillers, together with drugmaker Johnson & Johnson and the three largest U.S. drug distributors.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

(photo credit: REUTERS/BAZ RATNER)

ByREUTERS

OCTOBER 24, 2019 10:08